Nanoscale CaV channel reorganization links α-synuclein pathology to calcium-dependent transcriptional dysregulation

preprint OA: closed CC-BY-NC-ND-4.0

Abstract

Disrupted calcium (Ca 2+ ) homeostasis is a hallmark of neurodegenerative diseases, yet the mechanisms driving excessive Ca 2+ entry at the neuronal plasma membrane remain poorly understood. Here, we show that α-synuclein pre-formed fibrils trigger a reorganization of voltage-gated calcium (Ca V ) channels in cultured mouse cortical neurons, increasing their clustering at the soma and dendrites. We find that α-synuclein fibrils promote cyclin-dependent kinase 5–mediated phosphorylation of K V 2.1 at serine 603, enhancing its scaffolding capacity for Ca V channels. Disrupting Ca V –K V 2.1 coupling with a competitive peptide or pharmacological CDK5 inhibition restores channel proximity to control levels. Functionally, the enhanced Ca V clustering amplifies depolarization-evoked Ca 2+ influx and drives aberrant excitation–transcription coupling, as reflected by elevated expression of the immediate early gene c-Fos. All effects were rescued by disrupting Ca V –K V 2.1 interactions or inhibiting Ca V channel activity. These findings identify nanoscale Ca V channel remodeling as a mechanistic link between α-synuclein pathology and Ca 2+ -dependent transcriptional dysregulation, positioning Parkinson’s disease as a nanostructural channelopathy.
Full text 1,323 characters · extracted from oa-html · click to expand
Abstract Disrupted calcium (Ca2+) homeostasis is a hallmark of neurodegenerative diseases, yet the mechanisms driving excessive Ca2+ entry at the neuronal plasma membrane remain poorly understood. Here, we show that α-synuclein pre-formed fibrils trigger a reorganization of voltage-gated calcium (CaV) channels in cultured mouse cortical neurons, increasing their clustering at the soma and dendrites. We find that α-synuclein fibrils promote cyclin-dependent kinase 5–mediated phosphorylation of KV2.1 at serine 603, enhancing its scaffolding capacity for CaV channels. Disrupting CaV–KV2.1 coupling with a competitive peptide or pharmacological CDK5 inhibition restores channel proximity to control levels. Functionally, the enhanced CaV clustering amplifies depolarization-evoked Ca2+ influx and drives aberrant excitation–transcription coupling, as reflected by elevated expression of the immediate early gene c-Fos. All effects were rescued by disrupting CaV–KV2.1 interactions or inhibiting CaV channel activity. These findings identify nanoscale CaV channel remodeling as a mechanistic link between α-synuclein pathology and Ca2+-dependent transcriptional dysregulation, positioning Parkinson’s disease as a nanostructural channelopathy. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-NC-ND-4.0